Lista de obras - Maria Koltowska-Häggström

Adaptation of the QoL-AGHDA scale for adults with growth hormone deficiency in four Slavic languages

artículo científico publicado en 2011

Application of the disease-specific Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) questionnaire in a general population: results from a French panel study

artículo científico publicado en 2010

Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations

artículo científico publicado en 2009

Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (

artículo científico publicado en 2005

Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database).

artículo científico publicado en 2004

Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic–pituitary dysfunction ⬇️

artículo científico publicado el 17 de septiembre de 2013

Clinical features of GH deficiency and effects of 3 years of GH replacement in adults with controlled Cushing's disease.

artículo científico publicado en 2010

Clinical implications of residual growth hormone (GH) response to provocative testing in adults with severe GH deficiency

artículo científico publicado en 2007

Comorbidity and cardiovascular risk factors in adult GH deficiency following treatment for Cushing's disease or non-functioning pituitary adenomas during childhood.

artículo científico publicado en 2012

Coping strategies have a strong impact on quality of life, depression, and embitterment in patients with Cushing's disease

artículo científico publicado en 2016

Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis

artículo científico publicado en 2006

Diabetes in patients with acromegaly treated with pegvisomant: observations from acrostudy.

artículo científico publicado en 2018

Diagnosis and management of acromegaly: the patient's perspective

artículo científico publicado en 2016

Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life?

artículo científico publicado en 2006

Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis

artículo científico publicado en 2014

Five-Year Postmarket Safety Experience With the Optimal Balance Technology Range of Hyaluronic Acid Fillers

artículo científico publicado en 2020

GH deficiency after traumatic brain injury: improvement in quality of life with GH therapy: analysis of the KIMS database

artículo científico publicado en 2015

GH deficiency during the transition period: clinical characteristics before and after GH replacement therapy in two different subgroups of patients ⬇️

artículo científico publicado el 1 de enero de 2012

GH replacement in hypopituitarism improves lipid profile and quality of life independently of changes in obesity variables

artículo científico publicado en 2008

Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy

artículo científico publicado en 2007

Growth hormone (GH) replacement therapy in GH deficient adults: Predictors of one-year metabolic and clinical response

artículo científico publicado en 2007

Healthcare utilization, quality of life and patient-reported outcomes during two years of GH replacement therapy in GH-deficient adults--comparison between Sweden, The Netherlands and Germany

artículo científico publicado en 2006

Impact of the primary aetiology upon the clinical outcome of adults with childhood-onset GH deficiency

artículo científico publicado en 2007

Incidence of diabetes mellitus and evolution of glucose parameters in growth hormone-deficient subjects during growth hormone replacement therapy: a long-term observational study

artículo científico publicado en 2011

Is growth hormone treatment in children associated with weight gain?--longitudinal analysis of KIGS data

artículo científico publicado en 2014

Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database

artículo científico publicado en 2005

Long-term safety of pegvisomant in patients with acromegaly: comprehensive review of 1288 subjects in ACROSTUDY.

artículo científico

Long-term treatment with pegvisomant as monotherapy in patients with acromegaly: experience from ACROSTUDY

artículo científico publicado en 2015

Magnetic resonance imaging of CNS in 15 043 children with GH deficiency in KIGS (Pfizer International Growth Database) ⬇️

artículo científico publicado el 17 de enero de 2013

Overall and cause-specific mortality in GH-deficient adults on GH replacement ⬇️

artículo científico publicado el 28 de marzo de 2012

Prediction of improvement in quality of life (QoL-AGHDA) in adults with growth hormone deficiency by normative reference limits: data of the German KIMS cohort

artículo científico publicado el 23 de agosto de 2011

Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis ⬇️

artículo científico publicado el 3 de octubre de 2011

Quality of life in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention--radial versus femoral access (from the OCEAN RACE Trial).

artículo científico publicado en 2014

Response to GH treatment in adult GH deficiency is predicted by gender, age, and IGF1 SDS but not by stimulated GH-peak ⬇️

artículo científico publicado el 15 de abril de 2013

Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database).

artículo científico publicado en 2010

Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database

artículo científico publicado en 2005

Similar Clinical Features Among Patients with Severe Adult Growth Hormone Deficiency Diagnosed with Insulin Tolerance Test or Arginine or Glucagon Stimulation Tests ⬇️

artículo científico publicado el 1 de mayo de 2012

Support Needs of Patients with Cushing's Disease and Cushing's Syndrome: Results of a Survey Conducted in Germany and the USA

article

The brazilian version of the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA): Four-stage translation and validation

artículo científico publicado en 2010

The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma

artículo científico publicado en 2005

The cost-effectiveness of growth hormone replacement therapy (Genotropin®) in hypopituitary adults in Sweden

artículo científico publicado en 2013

The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients.

artículo científico publicado en 2006

The metabolic consequences of thyroxine replacement in adult hypopituitary patients.

artículo científico publicado en 2012

The pituitary gland and age-dependent regulation of body composition.

artículo científico publicado en 2010

The presence of eye defects in patients with Turner syndrome is irrespective of their karyotype

artículo científico publicado en 2015

Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption.

artículo científico publicado en 2004

Traumatic brain injury as a relevant cause of growth hormone deficiency in adults: A KIMS-based study

artículo científico publicado en 2005

Which patients with acromegaly are treated with pegvisomant? An overview of methodology and baseline data in ACROSTUDY.

artículo científico publicado en 2009

[Comment on the HSAN decision concerning Cesarean section and spinal analgesia: Pregnant women must be confident that adequate anesthesia is always provided]

artículo científico publicado en 2009

Lista de obras de Maria Koltowska-Häggström

Adaptation of the QoL-AGHDA scale for adults with growth hormone deficiency in four Slavic languages

Application of the disease-specific Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) questionnaire in a general population: results from a French panel study

Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations

Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (

Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database).

Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic–pituitary dysfunction ⬇️

Clinical features of GH deficiency and effects of 3 years of GH replacement in adults with controlled Cushing's disease.

Clinical implications of residual growth hormone (GH) response to provocative testing in adults with severe GH deficiency

Comorbidity and cardiovascular risk factors in adult GH deficiency following treatment for Cushing's disease or non-functioning pituitary adenomas during childhood.

Coping strategies have a strong impact on quality of life, depression, and embitterment in patients with Cushing's disease

Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis

Diabetes in patients with acromegaly treated with pegvisomant: observations from acrostudy.

Diagnosis and management of acromegaly: the patient's perspective

Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life?

Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis

Five-Year Postmarket Safety Experience With the Optimal Balance Technology Range of Hyaluronic Acid Fillers

GH deficiency after traumatic brain injury: improvement in quality of life with GH therapy: analysis of the KIMS database

GH deficiency during the transition period: clinical characteristics before and after GH replacement therapy in two different subgroups of patients ⬇️

GH replacement in hypopituitarism improves lipid profile and quality of life independently of changes in obesity variables

Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy

Growth hormone (GH) replacement therapy in GH deficient adults: Predictors of one-year metabolic and clinical response

Healthcare utilization, quality of life and patient-reported outcomes during two years of GH replacement therapy in GH-deficient adults--comparison between Sweden, The Netherlands and Germany

Impact of the primary aetiology upon the clinical outcome of adults with childhood-onset GH deficiency

Incidence of diabetes mellitus and evolution of glucose parameters in growth hormone-deficient subjects during growth hormone replacement therapy: a long-term observational study

Is growth hormone treatment in children associated with weight gain?--longitudinal analysis of KIGS data

Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database

Long-term safety of pegvisomant in patients with acromegaly: comprehensive review of 1288 subjects in ACROSTUDY.

Long-term treatment with pegvisomant as monotherapy in patients with acromegaly: experience from ACROSTUDY

Magnetic resonance imaging of CNS in 15 043 children with GH deficiency in KIGS (Pfizer International Growth Database) ⬇️

Overall and cause-specific mortality in GH-deficient adults on GH replacement ⬇️

Prediction of improvement in quality of life (QoL-AGHDA) in adults with growth hormone deficiency by normative reference limits: data of the German KIMS cohort

Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis ⬇️

Quality of life in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention--radial versus femoral access (from the OCEAN RACE Trial).

Response to GH treatment in adult GH deficiency is predicted by gender, age, and IGF1 SDS but not by stimulated GH-peak ⬇️

Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database).

Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database

Similar Clinical Features Among Patients with Severe Adult Growth Hormone Deficiency Diagnosed with Insulin Tolerance Test or Arginine or Glucagon Stimulation Tests ⬇️

Support Needs of Patients with Cushing's Disease and Cushing's Syndrome: Results of a Survey Conducted in Germany and the USA

The brazilian version of the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA): Four-stage translation and validation

The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma

The cost-effectiveness of growth hormone replacement therapy (Genotropin®) in hypopituitary adults in Sweden

The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients.

The metabolic consequences of thyroxine replacement in adult hypopituitary patients.

The pituitary gland and age-dependent regulation of body composition.

The presence of eye defects in patients with Turner syndrome is irrespective of their karyotype

Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption.

Traumatic brain injury as a relevant cause of growth hormone deficiency in adults: A KIMS-based study

Which patients with acromegaly are treated with pegvisomant? An overview of methodology and baseline data in ACROSTUDY.

[Comment on the HSAN decision concerning Cesarean section and spinal analgesia: Pregnant women must be confident that adequate anesthesia is always provided]